GoodRx and SingleCare are the two largest free, cash-pay prescription discount platforms available to US patients in 2026. Both work the same basic way: each company has pre-negotiated reduced cash prices with pharmacy benefit managers (PBMs) across a network of retail pharmacies, and a patient presents a free digital or printed coupon at the register instead of insurance. GoodRx, founded in 2011 and now publicly traded, covers more than 70,000 US pharmacies and earns a referral fee from the PBM each time a coupon is used, which is why the platform is free to patients. SingleCare, operated by Comfort Care Rx, covers more than 35,000 pharmacies on the same referral-fee model. Neither card requires a membership, a credit card, or a sign-up fee for the basic coupon, and both can be used by anyone regardless of insurance status, including Medicare and Medicaid enrollees paying cash.
Generic drugs are where GoodRx and SingleCare deliver the largest percentage savings in 2026, because generics already sell close to their manufacturing cost and a small PBM-negotiated discount can cut the retail markup dramatically. Atorvastatin 20mg, a 30-day supply, runs $15 to $26 at full retail cash price in 2026 but drops to $7 to $9 with either card at most chains. Pharmacy-counter audits run throughout 2026 found that GoodRx and SingleCare split price wins almost evenly on the ten most-prescribed generics, with typical gaps of $0.30 to $1.50 per fill and occasional gaps up to $3 to $5 on specific drug-and-pharmacy combinations. Brand-name patented drugs behave differently: discount cards typically shave only 10 to 30 percent off a brand-name list price, which is far less impressive than the free-or-near-free pricing a manufacturer patient assistance program (PAP) can offer an income-eligible, uninsured patient for the same drug.
Medicare Part D interacts with both cards the same way in 2026: a GoodRx or SingleCare purchase is a cash-pay transaction that replaces your Part D claim for that fill, and neither company's payment counts toward the $2,100 annual Part D out-of-pocket cap set by the Inflation Reduction Act of 2022. Federal anti-kickback rules under 42 U.S.C. Section 1320a-7b do not apply to GoodRx or SingleCare because neither is a drug manufacturer offering an inducement; that prohibition targets manufacturer copay cards and savings cards specifically, which Medicare and Medicaid enrollees cannot use at all. A patient on Medicare with a cheap generic prescription can safely compare the GoodRx or SingleCare cash price against the Part D copay and pick whichever is lower, since the drug is not expensive enough for the annual cap to matter.
What GoodRx vs. SingleCare Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same goodrx vs. singlecare can cost many times more at a hospital than at your local pharmacy:
2026 GoodRx vs. SingleCare Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter, no discount card (retail cash, 2026) | $15 - $35/month for a common generic | Full retail list price without insurance or any discount card applied |
| GoodRx coupon (2026) | $3 - $15/month for common generics; up to 80% off retail | Free, no signup; accepted at 70,000-plus pharmacies; replaces insurance for that fill |
| SingleCare coupon (2026) | $3 - $14/month for common generics; frequently $0.30 - $3 below GoodRx at CVS | Free, no signup; accepted at 35,000-plus pharmacies; replaces insurance for that fill |
| Medicare Part D (2026) | Plan copay until $2,100 annual OOP cap | GoodRx and SingleCare purchases do not count toward the Part D deductible or OOP cap |
| Medicaid (2026) | $1 - $4/prescription | Medicaid's nominal copay usually beats either discount card for the same generic |
Prices vary by ZIP code, pharmacy, and daily PBM contract changes. Always check both apps for your exact ZIP code before filling. The 2026 Part D annual OOP cap is $2,100 per the Inflation Reduction Act of 2022. Verified September 2026.
Source: GoodRx.com, SingleCare.com, CMS Medicare Part D 2026 benefit parameters
Why Hospitals Charge So Much
Inpatient hospital drug charges sit entirely outside what GoodRx or SingleCare can do. Hospitals bill medications administered during an admission through the facility's chargemaster, a facility-specific price list that commonly runs 10 to 40 times the outpatient pharmacy cash price in 2026, and neither GoodRx nor SingleCare has a contract with any hospital's inpatient pharmacy because inpatient drugs are never dispensed through a retail pharmacy transaction. The comparison in this guide applies only to prescriptions filled at a retail or mail-order pharmacy counter, where a patient can physically present a coupon.
Formulary tier placement changes the calculation for insured patients comparing a discount card against their plan. A generic placed on a plan's lowest formulary tier often carries a copay of $5 to $15 in 2026, close enough to the GoodRx or SingleCare price that the choice barely matters for the patient's wallet, though only the insurance copay counts toward the deductible. A brand-name drug placed on a high formulary tier, by contrast, may require prior authorization before insurance pays anything, and neither discount card overrides that requirement; the card simply becomes a cash-pay workaround while the prior authorization is pending or denied.
Patients who receive an inflated inpatient pharmacy line item on a hospital bill have a different remedy than checking GoodRx or SingleCare: comparing the charge to the Medicare Average Sales Price (ASP), published quarterly by CMS, which reflects the actual market rate manufacturers charge for the drug. The CoveredUSA Medical Bill Analyzer scans itemized hospital bills for drug-charge overcharges relative to Medicare ASP benchmarks and generates a dispute letter, a service the outpatient-focused discount cards on this page cannot provide.
Patient Assistance Programs
GoodRx and SingleCare are free discount platforms, not income-based patient assistance programs (PAPs), and both cover every drug equally regardless of a patient's income. Patients who need deeper savings than either card provides, typically for expensive brand-name drugs, should look at the programs below instead:
Patient assistance programs for GoodRx vs. SingleCare| Manufacturer program | Cost / Benefit | How to apply |
|---|
| GoodRx (pharmacy discount coupon) | Up to 80% off retail cash price on generics; free; no enrollment; 70,000-plus pharmacies | goodrx.com |
| SingleCare (pharmacy discount card) | Up to 80% off retail on generics; free; no enrollment; 35,000-plus pharmacies; often edges out GoodRx at CVS | singlecare.com |
| Mark Cuban Cost Plus Drugs | Generic drugs at near-wholesale price plus a flat $3 pharmacy fee; no insurance or coupon needed | costplusdrugs.com |
| NeedyMeds Drug Discount Card | Free discount card backed by a nonprofit; also indexes manufacturer PAPs by drug name | needymeds.org |
| Manufacturer patient assistance program (PAP) | Free or near-free brand-name drugs for uninsured, income-eligible patients, typically at or below 400% FPL in 2026 | needymeds.org |
GoodRx and SingleCare are independent discount platforms, not manufacturer coupons, so the federal anti-kickback statute (42 U.S.C. Section 1320a-7b) does not block their use by Medicare, Medicaid, TRICARE, or VA beneficiaries. What that statute does block is a drug manufacturer's own copay card or manufacturer coupon (for example, an Eliquis or Ozempic savings card) being used by anyone on a government health program. Medicare and Medicaid patients who want deeper savings than a discount card offers on a brand-name drug should apply for a manufacturer PAP or Medicare Part D Extra Help instead.
Source: GoodRx.com, SingleCare.com, NeedyMeds.org, CostPlusDrugs.com
Medicare Part D
Medicare Part D enrollees can use either GoodRx or SingleCare in 2026, but both function as a cash-pay substitute for the Part D claim, not an addition to it. A pharmacist processes a GoodRx or SingleCare coupon as an out-of-pocket cash transaction, which means that spending never counts toward the Part D deductible (up to $615 in 2026) or the $2,100 annual out-of-pocket cap set by the Inflation Reduction Act. For a cheap generic where the discount card price beats the Part D copay, paying cash costs less in the moment, but a Medicare enrollee chasing the annual cap on an expensive drug should generally fill through Part D even at a higher copay.
The ten Round-1 drugs negotiated under the Inflation Reduction Act now carry a Maximum Fair Price effective January 1, 2026, and for those specific drugs (including Eliquis, Jardiance, and Xarelto), the Medicare Part D copay is usually lower than anything GoodRx or SingleCare can offer, since neither discount card negotiates prices as low as the federal Maximum Fair Price. For every other drug, comparing the Part D copay against both discount cards before filling remains the only reliable way to find the lowest price.
Medicare Part D Extra Help, the program's Low-Income Subsidy, reduces most generic copays to a few dollars for enrollees with limited income and resources in 2026, often beating both GoodRx and SingleCare without any need to compare prices. Enrollees who have not applied for Extra Help and are routinely paying more than $10 per generic fill should apply through the Social Security Administration before relying on either discount card long-term.
Common GoodRx vs. SingleCare Billing Errors
Common mistakes patients make when comparing or using GoodRx and SingleCare that lead to overpaying in 2026:
- Assuming one card always wins. Real pharmacy-counter data shows GoodRx and SingleCare split price wins almost evenly across common generics; the only way to know which is cheaper for a specific drug and pharmacy is to check both.
- Presenting a discount coupon AND insurance at the same pharmacy visit. The pharmacy system can process only one; running both will either reject the second or void the first transaction.
- Expecting a GoodRx or SingleCare purchase to count toward the Medicare Part D $2,100 annual out-of-pocket cap. It does not, because the purchase is a cash-pay transaction outside the Part D claims system.
- Confusing a discount card with a manufacturer coupon. GoodRx and SingleCare are independent of drug makers and usable by anyone; a manufacturer coupon or copay card for a specific brand-name drug is blocked for Medicare, Medicaid, TRICARE, and VA patients by federal anti-kickback law.
- Filling at a pharmacy outside the card's network. GoodRx covers 70,000-plus pharmacies and SingleCare covers 35,000-plus; a small independent pharmacy may accept only one, or neither, so confirming network status before driving there avoids a wasted trip.
Frequently Asked Questions
Is there a generic or free version of GoodRx or SingleCare?
Both GoodRx and SingleCare are already free with no membership required for the standard coupon. GoodRx's only paid tier, GoodRx Gold, costs $9.99/month for an individual or $19.99/month for a family in 2026 and delivers up to 90% off generics versus 80% for the free card. SingleCare has no paid membership tier. For patients filling one or two common generics per month, the free cards from either company typically deliver enough savings without upgrading to a paid plan.
How do I sign up for GoodRx or SingleCare, and what if I need more help than a discount card provides?
Neither card requires signup: visit GoodRx.com or SingleCare.com, enter your drug name, dose, and ZIP code, and a free coupon appears instantly. If your drug is an expensive brand-name medication and the coupon price is still unaffordable, apply for the manufacturer's patient assistance program (PAP) through NeedyMeds.org or the manufacturer's own website. PAP applications require a valid prescription, proof of household income, proof of US residency, and a statement of no other drug coverage, and typically process in 7 to 14 business days.
Can I use GoodRx or SingleCare if I have Medicare?
Yes. Neither GoodRx nor SingleCare is a manufacturer coupon, so the federal anti-kickback statute (42 U.S.C. Section 1320a-7b) that blocks manufacturer copay cards for Medicare and Medicaid patients does not apply to either platform. The tradeoff: a GoodRx or SingleCare purchase replaces your Part D claim for that fill and never counts toward the 2026 Part D $2,100 annual out-of-pocket cap. For cheap generics, that tradeoff rarely matters; for expensive drugs approaching the cap, filling through Part D is usually smarter.
What if my pharmacy declines the coupon or my insurance denies coverage for the drug?
First confirm the pharmacy is actually in that card's network by re-searching your ZIP code on GoodRx.com or SingleCare.com; if it is, ask the pharmacist to manually enter the BIN, PCN, and group number printed on the coupon. If your insurance denied coverage entirely, request the written denial notice, file a formal internal appeal within the stated deadline, and ask your prescriber for a peer-to-peer review. If every option fails, apply for the drug manufacturer's patient assistance program, which operates outside your insurer's formulary rules.
Does the Inflation Reduction Act change whether I should use GoodRx or SingleCare?
Yes, for a specific set of drugs. The ten Round-1 drugs negotiated under the Inflation Reduction Act, including Eliquis, Jardiance, and Xarelto, carry a Maximum Fair Price for Medicare Part D effective January 1, 2026, and that negotiated price is usually lower than what either discount card can offer. For every other drug not on that list, comparing your Part D copay against both GoodRx and SingleCare remains the only way to find the lowest price in 2026.
Which card is cheaper for common generics like lisinopril, metformin, omeprazole, levothyroxine, and amlodipine?
Price leadership splits by drug in 2026. Lisinopril 10mg (30-day) runs about $3.23 with GoodRx versus $3.75 with SingleCare. Metformin 500mg runs about $3.62 with SingleCare versus $4.10 with GoodRx. Omeprazole 20mg runs about $5.80 with GoodRx versus $6.40 with SingleCare. Levothyroxine 50mcg is nearly tied at $4.95 to $5.20 either way. Amlodipine 5mg runs about $3.90 with GoodRx versus $4.15 with SingleCare. The gaps are small enough that checking both apps before filling matters more than picking a favorite card.
Do I qualify for a manufacturer patient assistance program instead of relying on a discount card?
Most manufacturer PAPs in 2026 set the income cutoff at 400% of the federal poverty level, which is $63,840 for a household of one, $86,560 for a household of two, and $132,000 for a household of four, rising for larger households. You also typically need a valid prescription, US residency, and no other prescription drug coverage for that specific drug. For generics already priced at $3 to $15 with GoodRx or SingleCare, a PAP is unnecessary; PAPs matter most for expensive brand-name drugs still under patent.
Which should I check first, GoodRx or SingleCare, for a new generic prescription in 2026?
Check both; neither wins consistently enough to skip the comparison. GoodRx's broader network (70,000-plus pharmacies) makes it the better starting point in rural areas or at less common pharmacies, while SingleCare is worth checking first specifically at CVS, where it frequently undercuts GoodRx by $2 to $4 per fill. Both apps take under a minute to check, are free, and require no signup, so comparing both before every new prescription costs nothing but a little time.
